Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3751843010 | Product containing precisely bevacizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3751844016 | Bevacizumab 25 mg/mL solution for injection | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 5635801000241116 | bévacizumab 25 mg/mL, solution injectable | fr | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
| 5635811000241119 | médicament contenant précisément bévacizumab 25 mg par millilitre de solution injectable | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely bevacizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug) | Has basis of strength substance (attribute) | Bevacizumab (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely bevacizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| Product containing precisely bevacizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug) | Has precise active ingredient | Bevacizumab (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely bevacizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely bevacizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug) | Has concentration strength numerator value | 25 | false | Inferred relationship | Some | 1 | |
| Product containing precisely bevacizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug) | Has manufactured dose form | Solution for injection | true | Inferred relationship | Some | ||
| Product containing precisely bevacizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug) | Is a | Product containing only bevacizumab in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely bevacizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
| Product containing precisely bevacizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug) | Has concentration strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Product containing precisely bevacizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR